Chemist Robert Holton Dies at 81 After Developing Synthetic Method for Cancer Drug Taxol

Robert Holton, a chemist whose groundbreaking work led to the development of a widely used cancer treatment, passed away at the age of 81. Holton is credited with creating a synthetic method for producing Taxol, a chemotherapy drug that has become a critical tool in treating various forms of cancer. His innovation eliminated the need to extract the drug’s active compound from Pacific yew trees, which were endangered due to overharvesting.

Taxol was originally derived from the bark of these trees, but its production posed significant environmental concerns and supply limitations. Holton’s synthetic approach provided an alternative that preserved natural resources while ensuring consistent availability of the drug for medical use. Today, Taxol remains an essential part of cancer treatment protocols worldwide, benefiting countless patients and reducing reliance on ecological sources.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: July 2, 2025

Related posts:

Biosimilars Offer Up To 30% Cost Savings Compared to Originator Biologics, Drug Patent Watch Analysis Finds Vertical Integration Reshapes U.S. Drug Channels Amid Consolidation and Deconsolidation Trends Alvotech and Dr. Reddy’s Partner to Develop Biosimilar for Cancer Drug Pembrolizumab Concentra Biopharma Acquires Cargo Therapeutics Following Discontinuation of Lead CAR-T Therapy Candidate

Author

Mark Chiang